{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T22:56:05Z","timestamp":1783032965183,"version":"3.54.6"},"reference-count":53,"publisher":"Elsevier","isbn-type":[{"value":"9780443429835","type":"print"}],"license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025]]},"DOI":"10.1016\/bs.irn.2025.04.029","type":"book-chapter","created":{"date-parts":[[2025,7,23]],"date-time":"2025-07-23T08:33:19Z","timestamp":1753259599000},"page":"145-160","source":"Crossref","is-referenced-by-count":2,"title":["Animal models of myasthenia gravis"],"prefix":"10.1016","member":"78","reference":[{"key":"10.1016\/bs.irn.2025.04.029_bib901","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.cyto.2017.05.008","article-title":"Ablation of IL-17 expression moderates experimental autoimmune myasthenia gravis disease severity","volume":"96","author":"Aguilo-Seara","year":"2017","journal-title":"Cytokine"},{"issue":"6","key":"10.1016\/bs.irn.2025.04.029_bib1","doi-asserted-by":"crossref","DOI":"10.1111\/sji.13192","article-title":"T cell help in the autoreactive germinal center","volume":"95","author":"Akama-Garren","year":"2022","journal-title":"Scandinavian Journal of Immunology"},{"issue":"4","key":"10.1016\/bs.irn.2025.04.029_bib2","doi-asserted-by":"crossref","first-page":"2697","DOI":"10.4049\/jimmunol.172.4.2697","article-title":"Breakdown of tolerance to a self-peptide of acetylcholine receptor alpha-subunit induces experimental myasthenia gravis in rats","volume":"172","author":"Baggi","year":"2004","journal-title":"Journal of Immunology"},{"issue":"1","key":"10.1016\/bs.irn.2025.04.029_bib3","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s00005-011-0158-6","article-title":"Acetylcholine receptor-induced experimental myasthenia gravis: what have we learned from animal models after three decades?","volume":"60","author":"Baggi","year":"2012","journal-title":"Archivum Immunologiae et Therapiae Experimentalis"},{"issue":"5","key":"10.1016\/bs.irn.2025.04.029_bib902","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.4049\/jimmunol.147.5.1484","article-title":"The I-Abm12 mutation, which confers resistance to experimental myasthenia gravis, drastically affects the epitope repertoire of murine CD4+ cells sensitized to nicotinic acetylcholine receptor","volume":"147","author":"Bellone","year":"1991","journal-title":"Journal of Immunology"},{"issue":"8","key":"10.1016\/bs.irn.2025.04.029_bib903","doi-asserted-by":"crossref","first-page":"2589","DOI":"10.4049\/jimmunol.140.8.2589","article-title":"C5 gene influences the development of murine myasthenia gravis","volume":"140","author":"Christadoss","year":"1988","journal-title":"Journal of Immunology"},{"issue":"6","key":"10.1016\/bs.irn.2025.04.029_bib4","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1002\/ana.21371","article-title":"Anti-MuSK patient antibodies disrupt the mouse neuromuscular junction","volume":"63","author":"Cole","year":"2008","journal-title":"Annals of Neurology"},{"issue":"2","key":"10.1016\/bs.irn.2025.04.029_bib904","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.4049\/jimmunol.169.2.1077","article-title":"Resistance to experimental autoimmune myasthenia gravis in IL-6-deficient mice is associated with reduced germinal center formation and C3 production","volume":"169","author":"Deng","year":"2002","journal-title":"Journal of Immunology"},{"issue":"9","key":"10.1016\/bs.irn.2025.04.029_bib5","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1016\/j.autrev.2013.03.009","article-title":"Impairment of regulatory T cells in myasthenia gravis: Studies in an experimental model","volume":"12","author":"Gertel-Lapter","year":"2013","journal-title":"Autoimmunity Reviews"},{"issue":"1","key":"10.1016\/bs.irn.2025.04.029_bib905","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1002\/1521-4141(200101)31:1<225::AID-IMMU225>3.0.CO;2-0","article-title":"Disruption of the IL-1beta gene diminishes acetylcholine receptor-induced immune responses in a murine model of myasthenia gravis","volume":"31","author":"Huang","year":"2001","journal-title":"European Journal of Immunology"},{"key":"10.1016\/bs.irn.2025.04.029_bib6","doi-asserted-by":"crossref","first-page":"188","DOI":"10.3389\/fimmu.2014.00188","article-title":"Role of fused mycobacterium tuberculosis immunogens and adjuvants in modern tuberculosis vaccines","volume":"5","author":"Junqueira-Kipnis","year":"2014","journal-title":"Frontiers in Immunology"},{"issue":"10","key":"10.1016\/bs.irn.2025.04.029_bib906","doi-asserted-by":"crossref","first-page":"5236","DOI":"10.4049\/jimmunol.164.10.5236","article-title":"Absence of IFN-gamma or IL-12 has different effects on experimental myasthenia gravis in C57BL\/6 mice","volume":"164","author":"Karachunski","year":"2000","journal-title":"Journal of Immunology"},{"issue":"1-2","key":"10.1016\/bs.irn.2025.04.029_bib907","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0165-5728(98)00262-8","article-title":"Interleukin-4 deficiency facilitates development of experimental myasthenia gravis and precludes its prevention by nasal administration of CD4+ epitope sequences of the acetylcholine receptor","volume":"95","author":"Karachunski","year":"1999","journal-title":"Journal of Neuroimmunology"},{"issue":"1","key":"10.1016\/bs.irn.2025.04.029_bib7","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1002\/mus.23448","article-title":"Cell surface complement regulators moderate experimental myasthenia gravis pathology","volume":"47","author":"Kusner","year":"2013","journal-title":"Muscle & Nerve"},{"key":"10.1016\/bs.irn.2025.04.029_bib8","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.expneurol.2015.02.025","article-title":"Guidelines for pre-clinical assessment of the acetylcholine receptor--specific passive transfer myasthenia gravis model-Recommendations for methods and experimental designs","volume":"270","author":"Kusner","year":"2015","journal-title":"Experimental Neurology"},{"issue":"6","key":"10.1016\/bs.irn.2025.04.029_bib9","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1084\/jem.141.6.1365","article-title":"Experimental autoimmune myasthenia: A model of myasthenia gravis in rats and guinea pigs","volume":"141","author":"Lennon","year":"1975","journal-title":"The Journal of Experimental Medicine"},{"issue":"9","key":"10.1016\/bs.irn.2025.04.029_bib908","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1093\/intimm\/10.9.1359","article-title":"Experimental autoimmune myasthenia gravis induction in B cell-deficient mice","volume":"10","author":"Li","year":"1998","journal-title":"International Immunology"},{"key":"10.1016\/bs.irn.2025.04.029_bib10","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.expneurol.2015.03.010","article-title":"Standardization of the experimental autoimmune myasthenia gravis (EAMG) model by immunization of rats with Torpedo californica acetylcholine receptors--Recommendations for methods and experimental designs","volume":"270","author":"Losen","year":"2015","journal-title":"Experimental Neurology"},{"key":"10.1016\/bs.irn.2025.04.029_bib11","doi-asserted-by":"crossref","first-page":"53","DOI":"10.2147\/IJGM.S88552","article-title":"Animal models of myasthenia gravis: Utility and limitations","volume":"9","author":"Mantegazza","year":"2016","journal-title":"International Journal of General Medicine"},{"issue":"8","key":"10.1016\/bs.irn.2025.04.029_bib12","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1016\/j.immuni.2022.07.008","article-title":"Standing on the shoulders of mice","volume":"55","author":"Medetgul-Ernar","year":"2022","journal-title":"Immunity"},{"issue":"8","key":"10.1016\/bs.irn.2025.04.029_bib909","doi-asserted-by":"crossref","first-page":"2487","DOI":"10.1002\/(SICI)1521-4141(199808)28:08<2487::AID-IMMU2487>3.0.CO;2-Y","article-title":"IL-12 is involved in the induction of experimental autoimmune myasthenia gravis, an antibody-mediated disease","volume":"28","author":"Moiola","year":"1998","journal-title":"European Journal of Immunology"},{"key":"10.1016\/bs.irn.2025.04.029_bib13","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.expneurol.2017.08.006","article-title":"Immunization of mice with LRP4 induces myasthenia similar to MuSK-associated myasthenia gravis","volume":"297","author":"Mori","year":"2017","journal-title":"Experimental Neurology"},{"issue":"9","key":"10.1016\/bs.irn.2025.04.029_bib14","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1016\/j.autrev.2013.03.005","article-title":"Mechanisms associated with the pathogenicity of antibodies against muscle-specific kinase in myasthenia gravis","volume":"12","author":"Mori","year":"2013","journal-title":"Autoimmunity Reviews"},{"issue":"1","key":"10.1016\/bs.irn.2025.04.029_bib910","doi-asserted-by":"crossref","first-page":"604","DOI":"10.4049\/jimmunol.170.1.604","article-title":"Absence of IL-4 facilitates the development of chronic autoimmune myasthenia gravis in C57BL\/6 mice","volume":"170","author":"Ostlie","year":"2003","journal-title":"Journal of Immunology"},{"key":"10.1016\/bs.irn.2025.04.029_bib15","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.expneurol.2014.12.013","article-title":"Guidelines for pre-clinical animal and cellular models of MuSK-myasthenia gravis","volume":"270","author":"Phillips","year":"2015","journal-title":"Experimental Neurology"},{"issue":"3","key":"10.1016\/bs.irn.2025.04.029_bib911","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1006\/jaut.2001.0541","article-title":"HLA-DQ6 transgenic mice resistance to experimental autoimmune myasthenia gravis is linked to reduced acetylcholine receptor-specific IFN-gamma, IL-2 and IL-10 production","volume":"17","author":"Poussin","year":"2001","journal-title":"Journal of Autoimmunity"},{"issue":"1-2","key":"10.1016\/bs.irn.2025.04.029_bib912","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0165-5728(02)00030-9","article-title":"Role of IL-5 during primary and secondary immune response to acetylcholine receptor","volume":"125","author":"Poussin","year":"2002","journal-title":"Journal of Neuroimmunology"},{"issue":"1-2","key":"10.1016\/bs.irn.2025.04.029_bib913","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/S0165-5728(00)00385-4","article-title":"Suppression of experimental autoimmune myasthenia gravis in IL-10 gene-disrupted mice is associated with reduced B cells and serum cytotoxicity on mouse cell line expressing AChR","volume":"111","author":"Poussin","year":"2000","journal-title":"Journal of Neuroimmunology"},{"issue":"8","key":"10.1016\/bs.irn.2025.04.029_bib914","doi-asserted-by":"crossref","first-page":"4389","DOI":"10.4049\/jimmunol.170.8.4389","article-title":"B7-1 costimulatory molecule is critical for the development of experimental autoimmune myasthenia gravis","volume":"170","author":"Poussin","year":"2003","journal-title":"Journal of Immunology"},{"issue":"1-2","key":"10.1016\/bs.irn.2025.04.029_bib915","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.jneuroim.2008.03.007","article-title":"C5a is not involved in experimental autoimmune myasthenia gravis pathogenesis","volume":"196","author":"Qi","year":"2008","journal-title":"Journal of Neuroimmunology"},{"issue":"5774","key":"10.1016\/bs.irn.2025.04.029_bib16","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1038\/286738a0","article-title":"Monoclonal anti-acetylcholine receptor antibodies can cause experimental myasthenia","volume":"286","author":"Richman","year":"1980","journal-title":"Nature"},{"issue":"4","key":"10.1016\/bs.irn.2025.04.029_bib17","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1001\/archneurol.2011.2200","article-title":"Acute severe animal model of anti-muscle-specific kinase myasthenia: combined postsynaptic and presynaptic changes","volume":"69","author":"Richman","year":"2012","journal-title":"Archives of Neurology"},{"key":"10.1016\/bs.irn.2025.04.029_bib18","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.3389\/fimmu.2017.01029","article-title":"Use of toll-like receptor agonists to induce ectopic lymphoid structures in Myasthenia Gravis Mouse Models","volume":"8","author":"Robinet","year":"2017","journal-title":"Frontiers in Immunology"},{"issue":"1","key":"10.1016\/bs.irn.2025.04.029_bib19","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1172\/JCI115843","article-title":"Transplantation of thymic autoimmune microenvironment to severe combined immunodeficiency mice. A new model of myasthenia gravis","volume":"90","author":"Schonbeck","year":"1992","journal-title":"The Journal of Clinical Investigation"},{"issue":"12","key":"10.1016\/bs.irn.2025.04.029_bib20","doi-asserted-by":"crossref","first-page":"5190","DOI":"10.1172\/JCI66039","article-title":"Antibodies against low-density lipoprotein receptor-related protein 4 induce myasthenia gravis","volume":"123","author":"Shen","year":"2013","journal-title":"The Journal of Clinical Investigation"},{"key":"10.1016\/bs.irn.2025.04.029_bib21","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1196\/annals.1405.002","article-title":"Myasthenia gravis experimentally induced with muscle-specific kinase","volume":"1132","author":"Shigemoto","year":"2008","journal-title":"Annals of the New York Academy of Sciences"},{"issue":"1-2","key":"10.1016\/bs.irn.2025.04.029_bib22","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.jneuroim.2012.01.003","article-title":"DAF\/CD55 and Protectin\/CD59 modulate adaptive immunity and disease outcome in experimental autoimmune myasthenia gravis","volume":"244","author":"Soltys","year":"2012","journal-title":"Journal of Neuroimmunology"},{"issue":"1","key":"10.1016\/bs.irn.2025.04.029_bib916","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/1476-9255-9-20","article-title":"Complement regulatory protein Crry deficiency contributes to the antigen specific recall response in experimental autoimmune myasthenia gravis","volume":"9","author":"Soltys","year":"2012","journal-title":"Journal of Inflammation"},{"issue":"5","key":"10.1016\/bs.irn.2025.04.029_bib23","first-page":"1359","article-title":"Thymoma-associated myasthenia gravis. Transplantation of thymoma and extrathymomal thymic tissue into SCID mice","volume":"148","author":"Spuler","year":"1996","journal-title":"The American Journal of Pathology"},{"issue":"6","key":"10.1016\/bs.irn.2025.04.029_bib24","doi-asserted-by":"crossref","DOI":"10.3390\/cells13060508","article-title":"Recombinant acetylcholine receptor immunization induces a robust model of experimental autoimmune myasthenia gravis in mice","volume":"13","author":"Theissen","year":"2024","journal-title":"Cells"},{"issue":"2","key":"10.1016\/bs.irn.2025.04.029_bib25","doi-asserted-by":"crossref","first-page":"323","DOI":"10.3390\/vaccines2020323","article-title":"Immune adjuvant effect of molecularly-defined toll-like receptor ligands","volume":"2","author":"Toussi","year":"2014","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/bs.irn.2025.04.029_bib26","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.expneurol.2015.02.009","article-title":"Guidelines for standard preclinical experiments in the mouse model of myasthenia gravis induced by acetylcholine receptor immunization","volume":"270","author":"Tuzun","year":"2015","journal-title":"Experimental Neurology"},{"issue":"1-2","key":"10.1016\/bs.irn.2025.04.029_bib918","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.jneuroim.2006.07.016","article-title":"Complement regulator CD59 deficiency fails to augment susceptibility to actively induced experimental autoimmune myasthenia gravis","volume":"181","author":"T\u00fcz\u00fcn","year":"2006","journal-title":"Journal of Neuroimmunology"},{"issue":"7","key":"10.1016\/bs.irn.2025.04.029_bib919","doi-asserted-by":"crossref","first-page":"3847","DOI":"10.4049\/jimmunol.171.7.3847","article-title":"Genetic evidence for involvement of classical complement pathway in induction of experimental autoimmune myasthenia gravis","volume":"171","author":"T\u00fcz\u00fcn","year":"2003","journal-title":"Journal of Immunology"},{"issue":"5","key":"10.1016\/bs.irn.2025.04.029_bib27","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1080\/08820139.2017.1299754","article-title":"Immunization with recombinantly expressed LRP4 induces experimental autoimmune myasthenia gravis in C57BL\/6 Mice","volume":"46","author":"Ulusoy","year":"2017","journal-title":"Immunological Investigations"},{"issue":"13","key":"10.1016\/bs.irn.2025.04.029_bib28","article-title":"Functional monovalency amplifies the pathogenicity of anti-MuSK IgG4 in myasthenia gravis","volume":"118","author":"Vergoossen","year":"2021","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"1","key":"10.1016\/bs.irn.2025.04.029_bib29","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1111\/nyas.13543","article-title":"Passive transfer models of myasthenia gravis with muscle-specific kinase antibodies","volume":"1413","author":"Verschuuren","year":"2018","journal-title":"Annals of the New York Academy of Sciences"},{"issue":"11","key":"10.1016\/bs.irn.2025.04.029_bib920","doi-asserted-by":"crossref","first-page":"7072","DOI":"10.4049\/jimmunol.178.11.7072","article-title":"C57BL\/6 mice genetically deficient in IL-12\/IL-23 and IFN-gamma are susceptible to experimental autoimmune myasthenia gravis, suggesting a pathogenic role of non-Th1 cells","volume":"178","author":"Wang","year":"2007","journal-title":"Journal of Immunology"},{"issue":"1","key":"10.1016\/bs.irn.2025.04.029_bib921","doi-asserted-by":"crossref","first-page":"97","DOI":"10.4049\/jimmunol.172.1.97","article-title":"The susceptibility to experimental myasthenia gravis of STAT6-\/- and STAT4-\/- BALB\/c mice suggests a pathogenic role of Th1 cells","volume":"172","author":"Wang","year":"2004","journal-title":"Journal of Immunology"},{"issue":"7","key":"10.1016\/bs.irn.2025.04.029_bib922","doi-asserted-by":"crossref","first-page":"7550","DOI":"10.18632\/oncotarget.6885","article-title":"Novel CXCL13 transgenic mouse: inflammation drives pathogenic effect of CXCL13 in experimental myasthenia gravis","volume":"7","author":"Weiss","year":"2016","journal-title":"Oncotarget"},{"issue":"4","key":"10.1016\/bs.irn.2025.04.029_bib30","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/S0301-0082(00)00055-1","article-title":"Safety factor at the neuromuscular junction","volume":"64","author":"Wood","year":"2001","journal-title":"Progress in Neurobiology"},{"key":"10.1016\/bs.irn.2025.04.029_bib923","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1196\/annals.1254.044","article-title":"Induction of myasthenia gravis in HLA transgenic mice by immunization with human acetylcholine receptors","volume":"998","author":"Yang","year":"2003","journal-title":"Annals of the New York Academy of Sciences"},{"issue":"7","key":"10.1016\/bs.irn.2025.04.029_bib924","doi-asserted-by":"crossref","first-page":"3775","DOI":"10.4049\/jimmunol.162.7.3775","article-title":"Mice with IFN-gamma receptor deficiency are less susceptible to experimental autoimmune myasthenia gravis","volume":"162","author":"Zhang","year":"1999","journal-title":"Journal of Immunology"}],"container-title":["International Review of Neurobiology","Myasthenia Gravis: Part A"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0074774225000443?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0074774225000443?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,23]],"date-time":"2025-07-23T09:44:33Z","timestamp":1753263873000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0074774225000443"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"ISBN":["9780443429835"],"references-count":53,"URL":"https:\/\/doi.org\/10.1016\/bs.irn.2025.04.029","relation":{},"ISSN":["0074-7742"],"issn-type":[{"value":"0074-7742","type":"print"}],"subject":[],"published":{"date-parts":[[2025]]}}}